C3.ai (NYSE:AI) Given New $24.00 Price Target at JMP Securities

C3.ai (NYSE:AI) had its price objective reduced by analysts at JMP Securities from $30.00 to $24.00 in a report released on Thursday,Benzinga reports. The firm presently has a “market outperform” rating on the stock. JMP Securities’ price objective would indicate a potential upside of 44.09% from the company’s previous close.

Other analysts also recently issued research reports about the company. Wall Street Zen downgraded C3.ai from a “hold” rating to a “sell” rating in a research report on Saturday, August 16th. Needham & Company LLC reaffirmed a “hold” rating on shares of C3.ai in a research report on Thursday. Oppenheimer reaffirmed a “market perform” rating on shares of C3.ai in a research report on Tuesday, August 12th. Northland Securities downgraded C3.ai from an “outperform” rating to a “market perform” rating and set a $17.00 target price on the stock. in a research report on Tuesday, August 12th. Finally, Morgan Stanley lifted their target price on C3.ai from $20.00 to $22.00 and gave the company an “underweight” rating in a research report on Thursday, May 29th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, eight have issued a Hold rating and five have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, C3.ai presently has a consensus rating of “Reduce” and a consensus target price of $24.21.

C3.ai Price Performance

AI opened at $16.66 on Thursday. The business’s 50-day moving average price is $22.60 and its two-hundred day moving average price is $22.91. C3.ai has a 1 year low of $14.70 and a 1 year high of $45.08. The company has a market capitalization of $2.24 billion, a price-to-earnings ratio of -7.44 and a beta of 1.96.

C3.ai (NYSE:AI) last released its quarterly earnings results on Wednesday, September 3rd. The company reported ($0.86) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.65). C3.ai had a negative net margin of 74.21% and a negative return on equity of 33.51%. The firm had revenue of $70.26 million during the quarter, compared to analyst estimates of $104.02 million. During the same period in the prior year, the business earned ($0.05) EPS. The business’s revenue for the quarter was down 19.4% compared to the same quarter last year. C3.ai has set its Q2 2026 guidance at EPS. Sell-side analysts anticipate that C3.ai will post -2.44 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other C3.ai news, Director John E. Hyten sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $23.75, for a total transaction of $237,500.00. Following the transaction, the director owned 63,942 shares of the company’s stock, valued at $1,518,622.50. The trade was a 13.52% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Merel Witteveen sold 5,485 shares of the business’s stock in a transaction that occurred on Monday, June 16th. The stock was sold at an average price of $23.95, for a total value of $131,365.75. Following the transaction, the vice president directly owned 13,740 shares in the company, valued at approximately $329,073. This trade represents a 28.53% decrease in their position. The disclosure for this sale can be found here. Insiders sold 2,162,768 shares of company stock worth $50,525,604 in the last three months. 26.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On C3.ai

Institutional investors have recently made changes to their positions in the company. Orion Capital Management LLC bought a new stake in shares of C3.ai during the fourth quarter worth approximately $34,000. Raiffeisen Bank International AG bought a new stake in shares of C3.ai in the fourth quarter valued at approximately $36,000. Garde Capital Inc. bought a new stake in shares of C3.ai in the first quarter valued at approximately $29,000. CX Institutional bought a new stake in shares of C3.ai in the first quarter valued at approximately $34,000. Finally, Versant Capital Management Inc boosted its stake in shares of C3.ai by 417.5% in the first quarter. Versant Capital Management Inc now owns 1,868 shares of the company’s stock valued at $39,000 after buying an additional 1,507 shares during the period. Institutional investors own 38.96% of the company’s stock.

C3.ai Company Profile

C3.ai, Inc operates as an enterprise artificial intelligence (AI) software company in North America, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides C3 AI platform, an application development and runtime environment that enables customers to design, develop, and deploy enterprise AI applications; C3 AI Ex Machina for analysis-ready data; C3 AI CRM, an industry specific customer relationship management solution; and C3 Generative AI Product Suite that enables to locate, retrieve, and present information.